Iterum Therapeutics Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 14, 2024
-- ORLYNVAHTM Approved by FDA on October 25, 2024—
--Company to Host Conference Call Today at 8:30 a.m. EDT--
Read more at globenewswire.com0.4172
+0 (+0.77%)
Find more stocks in the Stock Screener
ITRM Latest News and Analysis
20 days ago - By: Chartmill
